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 Abstract 
 Laboratory medicine’s practitioners across the European 
community include medical, scientifi c and pharmacy trained 
specialists whose contributions to health and healthcare is 
in the application of diagnostic tests for screening and early 
detection of disease, differential diagnosis, monitoring, 
management and treatment of patients, and their prognos-
tic assessment. In submitting a revised common syllabus for 
post-graduate education and training across the 27 member 
states an expectation is set for harmonised, high quality, 
safe practice. In this regard an extended ‘Core knowledge, 
skills and competencies’ division  embracing all laboratory 
medicine disciplines is described. For the fi rst time the syl-
labus identifi es the competencies required to meet clinical 
leadership demands for defi ning, directing and assuring 
the effi ciency and effectiveness of  laboratory services as 
well as expectations in translating knowledge and skills 
into ability to practice. In a ‘Specialist knowledge’ division, 
the expectations from the individual disciplines of Clinical 
Chemistry/Immunology, Haematology/Blood Transfusion, 
Microbiology/ Virology, Genetics and In Vitro Fertilisation 
are described. Beyond providing a common platform of 
knowledge, skills and competency, the syllabus supports the 
aims of the European Commission in providing safeguards 
to increasing professional mobility across European borders 
at a time when demand for highly qualifi ed professionals is 
increasing and the labour force is declining. It continues to 
act as a guide for the formulation of national programmes 
supplemented by the needs of individual country priorities. 
 Keywords:  competence to practice;  continuous professional 
development;  education;  leadership;  quality;  specialist in lab-
oratory medicine;  training. 
 Introduction 
 It has been estimated that up to 70 % of all medical decisions 
are based on data and information provided by laboratory 
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medicine  (1, 2) . It is the clinical specialty that underpins 
modern medicine ’ s understanding of health and disease. Its 
contributions include screening and early detection of dis-
ease, differential diagnosis, monitoring, management and 
treatment of patients, and their prognostic assessment. This 
contribution continues to grow through research and develop-
ment, technological advances and the increasing knowledge 
and skills base of its practitioners across the 27 European 
Union (EU) member states. Central to extending that base 
is a syllabus for education and training that is fi t for purpose 
in meeting modern medicine ’ s demands for better health and 
best care. 
 The European Communities Confederation of Clinical 
Chemistry ’ s (EC4) syllabus for clinical chemistry and labo-
ratory medicine was fi rst published in 1997  (3) . This is its 
fourth revision. The syllabus describes the level of knowl-
edge and skills required from specialists, who have respon-
sibility for patient care, but recognises that the scope of 
practice varies across the member states  (4) , in part depend-
ing on whether:
 the specialist is from a medical, scientifi c or pharmacy (a) 
background. Medical practitioners comprise about one 
third of such specialists, their key additional contribution 
being the provision of direct patient care; 
 the specialisation is monovalent (typically clinical chem-(b) 
istry, the largest discipline) or polyvalent (to include one 
or more of haematology, blood transfusion, microbiology, 
virology, parasitology, immunology, genetics, reproduc-
tive medicine). 
 The overlap in scope, however, is considerable such that 
common elements in education and training can be identi-
fi ed in a unifi ed syllabus. Since the last revision was pub-
lished in 2005  (5) , much has changed in terms of the demands 
placed on the specialist and the service that he/she provides. 
In part these changes are predicated by individual member 
states ’ priorities but, increasingly, common themes emerge in 
the provision of healthcare across the European Community. 
Changes include:
 Greater clinical governance expectations for evidence-(a) 
based protocol-driven care which place new expectations 
for design of appropriate pathways involving diagnostic 
tests; 
 Increasing demands for professionals to be registered (b) 
and/or professional practice to be regulated so that the 
public and patients are protected in the knowledge that 
safe care is provided by individuals whose competency 
is maintained through continuous professional develop-
ment and/or re-validation; 
 A shift from voluntary to mandatory accreditation of (c) 
services that expects standards to be met in areas, such 
as laboratory management and personnel, premises and 
environment, technology and information systems, pre-
analytical and post-analytical phases, audit, evaluation, 
quality assurance and its management  (6, 7) ; 
 Technological advances in areas, such as proteomics, (d) 
molecular diagnostics and mass spectrometry. These 
advances cross discipline-specifi c barriers, allowing en-
hanced diagnostic accuracy, but place new knowledge 
and skill demands on laboratory services; 
 Increasing interest in exploitation of near patient testing (e) 
as a means of enhancing clinical, fi nancial and organisa-
tional outcomes; 
 Increasing prioritisation to improving public health as a (f) 
means of reducing later hospital admissions and costly 
care. 
 A syllabus fi t for purpose 
 The changes in professional and clinical expectations are 
refl ected in a revised content and structure of the syllabus  – 
 ‘ Core knowledge, skills and competencies ’ describes common 
expectations across laboratory medicine followed by special-
ist knowledge relating to Clinical Chemistry/Immunology, 
Haematology/Blood Transfusion, Microbiology/Virology, 
Genetics and in vitro fertilisation. Amongst the most sig-
nifi cant revisions under core knowledge  ‘ Laboratory 
Management and Quality Assurance ’ refl ects enhanced 
expectations for direction, leadership, organisation, qual-
ity, education/training, safety, legal, ethical and governance 
considerations;  ‘ Research and Development ’ has been exten-
sively revised and identifi es commitment to audit; enhanced 
roles in results interpretation and patient intervention are 
refl ected in a revised  ‘ Case-related clinical evaluation of lab-
oratory tests ’ . The specialist knowledge sections have been 
retained for this revision. 
 Overarching the new structure is the identifi cation of com-
petencies as measures of fi tness to practice and provide clini-
cal leadership in defi ning a service, identifying the resources 
required to support effi ciency and effectiveness whilst meet-
ing national medico-legal and regulatory requirements. The 
competencies identifi ed here complement those identifi ed by 
Beastall et al.  (8) and Gurr et al.  (9) as being appropriate for, 
respectively,  ‘ consultant ’ and  ‘ specialist ’ level practise. They 
are broken down to be associated with the individual sections. 
In identifying competencies the distinct contribution of the 
specialist in ensuring high quality, safe practice is underlined. 
They provide the standards of profi ciency that must be met, 
e.g., for registration and regulation purposes. They can also 
provide the cornerstone measures for individual appraisal and 
personal development. 
 Recognising professional qualifi cations 
 To date, the European Register of Specialists in Clinical 
Chemistry and Laboratory Medicine  (10) has recogni-
sed over 2500 individuals across the EU as being able to 
demonstrate:
 At least 9 years of undergraduate and post-graduate (a) 
study; 
 A minimum of 5 years specialist training in an approved (b) 
laboratory to a level at least equivalent to that in the 
European syllabus; 
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 Inclusion on a professional register in their home country; (c) 
 Participation in continuous professional development (d) 
activities. 
 Since its inception in 1997, registrants have held the title 
European Specialist in Clinical Chemistry and Laboratory 
Medicine ( EurClinChem ). The Register is a key facilitator 
in disseminating high quality practice and extending recog-
nition of the profession. The weight of its argument comes 
from the growing numbers of specialists wishing to join it, 
the quality of its argument from the standards it sets  (11, 
12) . Potentially the Register acts as a key inventory item 
for establishing a common mechanism for automatic recog-
nition of professional qualifi cations across Europe for the 
two thirds of specialists with a pharmacy or science training 
background  (13) . Currently only medically qualifi ed spe-
cialists enjoy the automatic recognition that allows profes-
sional mobility across European borders. Such mobility is 
important in supporting individual choice and encouraging 
a more equitable distribution of human resources and exper-
tise across the EU at a time when demand for highly quali-
fi ed professionals is increasing whilst the labour force is 
declining  (14, 15) . The identifi cation of competencies in the 
revised syllabus hence takes on additional signifi cance in 
allowing practitioners to demonstrate their ability to deliver 
common expectations for high quality, safe practice across 
European borders. 
 In 2007 EC4 merged with the Forum of European Societies 
of Clinical Chemistry and Laboratory Medicine (FESCC) 
to form the European Federation of Clinical Chemistry and 
Laboratory Medicine (EFCC)  (16) . A key initiative in 2011 of 
the newly formed organisation has been to replace the 1997 
 EurClinChem title with the term Specialist in Laboratory 
Medicine. In unifying previous descriptors the new term pro-
vides a common theme to the profession as well as clarity to 
the general public. Its adoption also brings individual disci-
plines and their national societies together under a common 
umbrella of infl uence to enhance high quality practice across 
the EU. 
 This paper is the report of a working group which has 
been endorsed by the Executive Board of EFCC after two 
rounds of consultation with national society representa-
tives on the EC4 Register Commission who commented 
on manuscripts and contributed with examples of their 
national education and training programmes. The outcome 
is a framework that is capable of interpretation by gov-
ernments and national societies in individual EU coun-
tries to help deliver a common approach to education and 
training. 
 Laboratory medicine: core knowledge, skills and 
competencies 
 I. Basic knowledge requirements 
1.  Knowledge of the structure and function of the cell. 
2.  Understanding of the chemical, cellular and tissue level 
of organisation of the body. 
   3.  Understanding of normal anatomy, physiology and pathol-
ogy of the body across the integumentary, skeletal, ner-
vous, cardiovascular (including blood, blood vessels and 
lymphatic system), respiratory, endocrine, renal, gastro-
intestinal (including nutrition), urinary system, reproduc-
tive system. 
  4.  Knowledge of the process by which embryonic develop-
ment occurs from conception to birth. 
  5.  Knowledge of the principles of inheritance, DNA and 
genetics including carrier status, genetic crosses/pedigree/
punnet squares/cross diagrams. 
   6.  Knowledge of the cellular, tissue and systems responses 
to disease including cell death, infl ammation, neoplasia, 
hypertrophy, hyperplasia, tissue responses to injury and 
repair. 
   7.  Describe the pathophysiology of disease development in 
common diseases across the body systems. 
   8.  Understand the basic principles of microbiology inclu-
ding infection control, bacteria, recognition of extracel-
lular pathogens, virus types and structures, viral infection 
and replication. 
  9.  Understand the basic principles of immunology, natural 
defences, B and T cell-mediated immune responses. 
 10.  Understand the basic principles of clinical biochemis-
try and metabolism in physiological, homeostatic and 
pathophysiological processes. 
 11.  Understand the basic principles of haematology including 
anaemias, haematological malignancies, blood clotting 
disorders. 
12.  Understand the basic principles of histology including 
microscopic and staining techniques. 
 Competencies
 Thorough knowledge of all aspects of clinical laboratory • 
sciences relevant to the discipline practiced. 
 Broad knowledge of, and insight into, biochemical pro-• 
cesses in human health and disease on a general and 
patient-specifi c level. 
 II. Indications for laboratory medicine procedures 
 In the early detection of disease or disease susceptibility, 1. 
screening, and in epidemiology. 
 In disease related diagnosis. 2. 
 In organ related diagnosis. 3. 
 In monitoring vital functions and predicting disease 4. 
outcome. 
 In treatment targeting, predicting and monitoring the 5. 
response to therapy. 
 Indications for subsequent specialised examinations. 6. 
 Indications for functional tests. 7. 
 Prognostic assessment. 8. 
 Competencies
 Appreciation of developments in science and technology • 
and in the understanding of disease in order to ensure the 
appropriate use of laboratory investigations. 
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 III. Infl uence of collection and storage of specimens 
 Place and time of sample collection, preservation, infl u-1. 
ence of nutrition, drugs, posture, fasting state, etc. 
 Choice and correct use of anticoagulants and transport 2. 
media, order of draw, tourniquet effects. 
 Care of the specimens, patient identifi cation, transport, 3. 
storage, stability of analytes, infl uence of temperature, 
freezing/thawing. 
 Competencies
 Recognition of pre-analytical factors that infl uence the • 
validity of the analytical process; 
 Ability to deliver the pre-analytical requirements of a labo-• 
ratory medicine service. 
 IV. Analytical principles and techniques 
 Separation techniques1. 
i.  Chromatography  – liquid, gas, thin layer, column, high 
pressure, affi nity. 
ii.  Electrophoresis  – gel, capillary zone, iso-electric 
focussing. 
iii.  Dialysis. 
iv.  Centrifugation  – ultracentrifugation. 
 Standard analytical techniques2. 
i.  Titrimetry. 
ii.  Osmometry. 
 Photometric methods3. 
 i. Spectrophotometry  – ultra violet, visible. 
ii.  Atomic absorption. 
iii.  Turbidimetry. 
iv.  Nephelometry. 
v.  Fluorimetry. 
vi.  Flame emission. 
vii.  Refl ectometry. 
 Spectrometric methods4. 
i.  Mass spectrometry, tandem mass spectrometry. 
ii.  Nuclear magnetic resonance. 
iii.  Infra-red. 
 Electrochemical techniques5. 
i.  Ion selective electrodes. 
ii.  Biosensos. 
iii.  Impedance (cell counting). 
 Nucleic acid analysis6. 
i.  Extraction and preparation of DNA and RNA. 
ii.  Polymerase chain reaction (PCR) and reverse PCR. 
iii.  Quantitative PCR. 
iv.  Techniques for point mutation detection. 
v.  Techniques for detecting more complex genetic 
variation. 
vi.  Cytogenetic analysis. 
vii.  Array technology, DNA sequencing, FISH. 
 Immunological techniques7. 
i.  Principles of Ag-Ab reactions, immunoassay design. 
ii.  Competitive immunoassay. 
iii.  Non-competitive immunoassay. 
iv.  Homogeneous and heterogeneous assays. 
v.  Interference. 
vi.  Signal detection systems  – use of radioisotopes, colo-
rimetic/fl uorimetric labels. 
vii.  Immuno-precipitation  – immunoelectrophoresis, immun-
ofi xation, immuno-turbidimetry, immunonephelometry. 
viii.  Agglutination techniques. 
 Enzymes8. 
i.  Analytical techniques  – reaction rate, end point analyses. 
ii.  Enzymes as reagents.  
iii.  Enzyme kinetics, inhibitors, allosteric behaviour. 
 Microscopy  – light, brightfi eld, phase-contrast, polarising, 9. 
interference contrast, darkfi eld, fl uorescence micro scopy. 
 Haematological cell staining techniques and preparation 10. 
of smears, slides or fi lms. 
 Flow cytometry11. 
i.  Cell counting, cell markers detection and fl uorochromes. 
ii.  Subsystems: fl uidics, optics and electronics. 
 Rheology .12. 
 Culture and sensitivity: microbial culturing, selection 13. 
of media, incubation conditions, organism identifi cation 
techniques, antibiotic sensitivity testing. 
 Microbial cell staining techniques  – microbe, virus, 14. 
parasite and fungus identifi cation (including principal dif-
ferential characteristics). 
 Competencies
 Knowledge of, and insight into, the use of technology and • 
analytical techniques relevant to the fi eld of specialisation, 
an active appreciation of developments, and an attitude of 
innovation and creativity in their implemen tation. 
 V. Analytical evaluation of laboratory methods 
 Precision, accuracy, sensitivity, specifi city. 1. 
 Interference. 2. 
 Analytical and clinical ranges, limits of detection, carry over. 3. 
 Internal quality assurance and external quality assessment. 4. 
 Statistical comparison of methods. 5. 
 Defi nitive methods, reference methods, primary and sec-6. 
ondary calibrants, traceability. 
 Laboratory and population data: sampling, reference values. 7. 
 Negative and positive predictive values of results; diag-8. 
nostic sensitivity and specifi city, diagnostic accuracy; 
liklelihood ratios. 
 Confi dence intervals. 9. 
 Competencies
 Ability to determine the essential parameters required to • 
evaluate a laboratory method. 
 Ability to conduct an evaluation using appropriate statisti-• 
cal tools, computer-aided spreadsheets and databases. 
 Ability to determine the clinical signifi cance of the out-• 
come of a laboratory method evaluation. 
 VI. Clinical evaluation of laboratory methods 
 Reference intervals and biological variability. 1. 
 Genetic infl uences, environmental infl uences, age, sex, nutri-
tion, season and time of day, infl uence of therapeutic agents. 
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 Clinical sensitivity, specifi city and predictive value of ana-2. 
lytical methods .
 Diagnostic strategies and analytical goals in the use of 3. 
clinical chemistry tests. 
 Competencies
 Ability to obtain, explore, and employ knowledge and • 
methods of investigation in the interests of health care and 
humankind. 
 Ability to take responsibility for the data and information • 
produced, including knowledge of the infl uence of varia-
tion (biological as well as analytical) on interpretation of 
data. 
 VII. Case-related medical evaluation of laboratory tests 
 The specialist in laboratory medicine in a consultative role 
requires a working knowledge of the subject underlying the 
choice of tests and interpretation of results. 
 Evaluation of individual results (identifying extreme 1. 
values, recognition of signifi cance of previous results, rec-
ognition of combinations of fi ndings typical of diseases). 
 Use of reference values: infl uence of age, genetics, sex, 2. 
lifestyle, interfering factors, effect of therapeutic agents, 
biological and analytical variation. 
 Longitudinal evaluation of critical differences during dis-3. 
ease course, e.g., in long-term conditions, cancer, during 
therapeutic drug monitoring and as a result of treatment 
regimen changes. 
 Recommended testing strategies in response to clinical 4. 
demand for intervention and guidance. 
 Independent initiation and/or recommendation of further 5. 
investigations, refl ective testing. 
 The laboratory report  – provision of evaluation, guidance 6. 
and interpretive comments. 
 Competencies
 Provision of interpretive, advisory and intervention guid-• 
ance in the application of laboratory tests, as appro priate. 
 Ability to communicate the value of laboratory investiga-• 
tions to service users. 
 VIII. Clinical training 
 Training requires exposure to clinical environments where 
laboratory medicine impacts on patient care. Examples 
include accident and emergency, critical care, and applica-
tions of point of care testing. Participation in ward rounds, 
provision of direct clinical care (as appropriate) as a member 
of the clinical team and other contact with the users of the lab-
oratory is key to achieving clinical competency. Participating 
and leading seminars, case discussions also provide valuable 
experience. 
 Competencies
 Ability to work in a multi-disciplinary environment • 
and function as a consulting advisor to his/her clinical 
colleagues and liaise with them in the choice of tests and 
the interpretation of laboratory results. 
 Understanding of the registrant ’ s responsibility in the prac-• 
tice of his/her profession to the well-being and personal 
safety of patients, colleagues, co-workers, the community, 
and the environment. 
 Ability to provide direct clinical care, as appropriate. • 
 IX. Research and development; audit 
 As laboratory medicine is continually and rapidly evolving, 
research and development of both the laboratory aspects and 
their clinical application are indispensable. The specialist in 
laboratory medicine must maintain up to date knowledge in 
all relevant diagnostic procedures. Special attention must be 
paid to the following: 
 Development and improvement in technologies, tech-1. 
niques and methodologies; with special emphasis on new 
developments in areas such as molecular biology, pro-
teomics, mass spectrometry. 
 Procedures to test and evaluate the steps of a method and 2. 
the components of an instrument. 
 Initiation, conduct and evaluation of laboratory-based and 3. 
clinical research and development based on best evidence 
of practice. 
 Initiation, conduct and evaluation of clinical and labora-4. 
tory audit to ensure quality, governance and patients ’ 
needs continue to be met. 
 Generating outcomes of research and development, audit 5. 
and service improvement programmes using recognised 
scientifi c and statistical techniques. 
 Competencies
 Ability to conduct research, either basic or applied, on • 
order to further knowledge in the fi eld of clinical chemistry 
and laboratory medicine. 
 Ability to undertake literature/systematic reviews and • 
design quantitative and qualitative programmes for re-
search, development, audit and service improvement based 
on best evidence. 
 Ability to appraise the need and set priorities for • 
research, development, audit and service improvement 
programmes. 
 Understanding of research governance, ethical and • 
legal frameworks, funding streams, the influence of 
regulatory and healthcare-related organisations in local 
settings. 
 Ability to design and conduct the required experiments to • 
ensure objectives are met. 
 The application of statistical and biostatistical procedures • 
to evaluate quantitative and qualitative information and 
data. 
 Ability to appraise and translate outcomes to enhance • 
activities, as appropriate. 
 Ability to communicate orally and in writing, including the • 
production of clear, cogent reports and publications in in-
ternational scientifi c journals. 
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 X. Laboratory management and quality assurance 
 Depending on the working environment the consultant should be 
familiar with some or all aspects of the responsibilities listed below. 
Some may be led on an organisation-wide basis, some fall within 
the remit of the lead consultant, some may also be delegated. 
 Laboratory direction and leadership1. 
 Specifying requirements. i. 
 Setting strategy and establishing policy. ii. 
 Formulating laboratory plans. iii. 
 Assessing resource requirements  – staff, space, equipment .iv. 
 Analysing costings (effi ciency) and cost-benefi ts v. 
(effectiveness). 
 Laboratory organisation2. 
 Design and utilisation of space and facilities. i. 
 Selection of methodologies and equipment. ii. 
 Selection of information management and technology iii. 
systems. 
 Recruiting and managing a staff/skill mix appropriate iv. 
for the service. 
 Establishing pre-analytical, analytical and post-ana-v. 
lytical processes. 
 Preparing protocols, procedures, guidelines. vi. 
 Budgetary responsibilities (contracting, performance vii. 
management, fi nancial controls). 
 Design of request and report forms. viii. 
 Quality3. 
 Medical laboratory and point of care testing accredita-i. 
tion systems .
 Requirements for a quality management system  – quality ii. 
assurance, governance, monitoring of planned actions. 
 Managing internal quality control and external quality iii. 
assessment performance. 
 Data management: use of medical informatics, data iv. 
processing, spread sheets/databases, electronic/
telecommunications. 
 Education/training/continuous professional development4. 
 Ensuring skills, competencies and motivation of staff i. 
meet service requirements .
 Ensuring staff access education and training pro-ii. 
grammes appropriate for service needs. 
 Participation, as appropriate, in staff education, train-iii. 
ing and appraisal. 
 Ensuring staff remain up to date by participation in iv. 
continuous professional development (CPD). 
 Ensuring own training, education, appraisal and CPD v. 
needs are maintained. 
 Laboratory safety5. 
 Handling of potentially infectious samples (e.g., HIV i. 
and hepatitis), handling of noxious chemicals and 
isotopes, mechanical and electrical safety, fi re precau-
tions, dealing with an accident, accident prevention 
and hygiene regulations, occupational diseases. 
 Alert systems, incident reporting. ii. 
 Legal, ethical and governance considerations6. 
 Laws, regulations, guidelines and recommendations on i. 
work in clinical laboratories: in particular requirements 
for accreditation of services, education and training, 
health and safety, infection control, buildings, employ-
ment law, regulation and registration of staff. 
 Ethical aspects and conventions on production, inter-ii. 
pretation, reporting and use of medical laboratory data. 
Confi dentiality, data protection and security .
 Clinical and research governance expectations of iii. 
government, health care-related organisations and em-
ployers for high quality, evidence-based care. 
 Competencies
 Ability to safeguard and protect the public against misuse • 
of medical laboratory investigations. 
 Knowledge of the principles of management leading to • 
satisfactory direction, supervision, and organisation of a 
laboratory department in a public or private hospital or in 
any other healthcare environment resulting in the provision 
of a competent service as laid down in a laboratory quality 
manual, based on good laboratory services as defi ned in 
EN-ISO document 15189 and the EC4 Essential Criteria. 
 Ability to determine the optimum distribution of resources • 
across central laboratories, peripheral sites and near patient 
testing settings. 
 Ability to assess confl icting and various technical, fi nancial, • 
and human considerations (e.g., care, quality, safety, cost, and 
time scales) both in the short- and long-term, and to fi nd the 
optimal solution in relation to patient care. 
 Ability to apply current techniques in human resource • 
management. 
 Execution of judgment and leadership. • 
 Laboratory medicine disciplines: specialist 
knowledge 
 Clinical chemistry/immunology 
 Carbohydrates1. 
 Glucose metabolism and regulation. • 
 Metabolism and regulation of other carbohydrates (e.g., • 
galactose, lactose, glycogen). 
 Type 1 and type 2 diabetes mellitus. Hypoglycaemic states. • 
 Other hereditary and acquired metabolic disorders (e.g., • 
lactose intolerance, galactosaemia, storage diseases). 
 Ketogenesis. • 
 Lipids and lipoproteins2. 
 Metabolism. • 
 Hereditary and acquired disorders. Storage diseases hy-• 
percholesterolaemia. Hypo- and hyper-lipoproteinaemia; 
characterisation by classical methodology; apolipopro-
teins; lipoprotein lipase. 
 Proteins and amino acids3. 
 Metabolism. • 
 Important plasma proteins (albumin, immunoglobulin, • 
haptoglobin, transferrin, C reactive protein, etc.). 
 Dysproteinaemia, monoclonal components. • 
 Tumour associated proteins. • 
 Hereditary and acquired disorders of amino acid • 
metabolism. 
 Urine proteins and proteinurias. • 
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 Nucleic acids and purines4. 
 Metabolism. • 
 Gout. • 
 Other hereditary and acquired disorders of purine • 
metabolism. 
 Porphyrins and haem pigments5. 
 Metabolism. • 
 Porphyrias. • 
 Biogenic amines6. 
 Metabolism. • 
 Catecholamines, serotonin and their breakdown • 
products. 
 Water and electrolytes7. 
 Metabolism. • 
 Sodium, potassium, chloride abnormalities. • 
 Osmolality. • 
 Overhydration, dehydration. • 
 Oedema, ascites. • 
 Acid-base, blood gases8. 
 Acid-base balance and disorders; buffer systems • 
(bicarbonate, phosphate, haemoglobin, protein); 
Henderson-Hasselbalch equation; acidosis and 
alkalosis .
 Renal regulation systems. • 
 Pulmonary gas exchange; oxygen metabolism. • 
 Iron metabolism 9. 
 Vitamins and trace elements 10. 
 Immune system11. 
 Functions of the humoral and cellular immune systems • 
and their regulation; cytokines; infl ammation; acute 
phase proteins. 
 Surface antigens. • 
 Hereditary and acquired disorders. • 
 Immunoglobulin defi ciency and overproduction, • 
monoclonal and polyclonal immunopathies. 
 Major histocompatibility complex. • 
 Autoimmune diseases; allergy. • 
 Complement factors. • 
 Infl ammation; cytokines; acute phase proteins. • 
 Enzymes12. 
 Induction, synthesis and elimination. • 
 Enzyme patterns in various tissues and body compart-• 
ments; isoenzymes; diagnostic signifi cance. 
 Cerebrospinal fl uid (CSF)13. 
 CSF synthesis and circulation. • 
 Composition of CSF in comparison to serum. • 
 Hereditary and acquired disorders of CSF • 
homeostasis. 
 Body fl uids other than CSF  – saliva, gastric juice, ascites, 14. 
chyle etc..
 Composition. • 
 Appropriate analyses. • 
 Digestive tract15. 
 Digestive enzymes in the various sections of the diges-• 
tive system including the exocrine functions of the liver 
and pancreas. 
 Hydrochloric acid, bicarbonate and bile secretion. • 
 Fluid and electrolyte secretion. • 
 Absorption. • 
 Gastrointestinal hormones. • 
 Hereditary and acquired disorders of the digestive • 
system. 
 Malabsorption including vitamin malabsorption. • 
 Exocrine functions of the pancreas16. 
 Acute pancreatitis. • 
 Chronic pancreatitis. • 
 Liver and biliary tract17. 
 Physiology; normal and disturbed functions of the • 
liver; metabolism, synthesis, biotransformation, 
excretion. 
 Enterohepatic circulation; metabolism of bilirubin and • 
bile acids. 
 Hepatitis, cirrhosis, cholestasis, necrosis. • 
 Kidneys and urinary tract18. 
 Physiology; normal and disturbed renal function. • 
 Excretory substances in the plasma and urine. • 
Glomerular fi ltration rate and clearance. Activity and 
effects of diuretics; free water clearance. 
 Proteinuria. • 
 Acute and chronic renal insuffi ciency, nephritis, neph-• 
rotic syndrome. 
 Heart and circulatory system19. 
 Normal and disturbed circulation. • 
 Myocardial infarction and shock; marker proteins; fl uid • 
balance. 
 Hypertension. • 
 Heart failure, blood markers. • 
 Skeletal and locomotor system20. 
 Function and metabolism of muscles, bones, car-• 
tilage, synovial and connective tissues (fasciae, 
tendons). 
 Hereditary and acquired disorders, especially of cal-• 
cium and phosphate metabolism, vitamin D, collagen 
and proteopolysaccharide metabolism. 
 Endocrine system21. 
 Physiology biosynthesis and catabolism of • 
hormones. 
 Hormonal regulation, hormone transport, receptor • 
systems. 
 Functional disorders of the thyroid gland, the parathy-• 
roid glands, the adrenal cortex, the adrenal medulla, the 
endocrine part of the pancreas, the gonads, the placenta, 
the pituitary-hypothalamus system. 
 Pregnancy, perinatal laboratory analysis22. 
 Hormone analyses; in vitro fertilisation. • 
 Molecular biology of hereditary disorders. • 
 Inherited metabolic disease. • 
 Pre-natal screening for foetal abnormalities (fi rst tri-• 
mester, second trimester). 
 Drug monitoring23. 
 Pharmokinetics, pharmacodynamics and bioavailabil-• 
ity of drugs, pharmacogenetics. 
 Therapeutic range. • 
 Individual determinations for the most impor-• 
tant drugs: digoxin, theophylline, anticonvulsants, 
immunosuppressants. 
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 Poisoning24. 
 Pathomechanisms of the most important types of • 
poisoning. 
 Knowledge of the preparation and preservation of spec-• 
imens, regulations for examination, documentation of 
examinations, chain of custody. 
 Knowledge of strategies for group recognition of poi-• 
sons by extraction, isolation and identifi cation. 
 Individual determinations for the most important types • 
of poisoning, e.g., ethylalcohol, carbon monoxide, 
barbiturates, benzodiazepines, tricyclic antidepres-
sants, methaemoglobin, methyalcohol, ethyleneglycol, 
benzene, toluene, etc... Cholinesterase in the case of or-
ganic phosphate intoxications .
 Tests for drugs of abuse. • 
 Radioactive isotope toxicology. • 
 Toxicology: drugs, opiates, cannabis, cocaine. • 
 Professional and environmental toxicology. • 
 Prenatal diagnosis of inborn errors of metabolism. 25. 
 Oncogenes/tumour markers. 26. 
 Haematology/blood transfusion (including cells, 
transfusion serology, coagulation, and cellular 
immunology) 
 Basic haematology1. 
 General morphology and blood cell counting. • 
 Determination of erythrocyte sedimentation rate. • 
Determination of haemoglobin concentration, haema-
tocrit, cell counts and knowledge of haematological 
parameters (MCV, MCH, MCHC, RDW). 
 Preparation and staining of blood smears, with micro-• 
scopical evaluation. 
 Investigation of haemolysis. • 
 Flow cytometry and leucocyte sub-grouping. • 
 General haemostasis2. 
 Coagulation tests. • 
 Determination of coagulation factors. Control of antico-• 
agulation factors, supervision of all treatments .
 Investigation of fi brinolysis. • 
 Determination of antithrombin III and heparin. • 
 Immuno-haematology3. 
 Blood group typing, ABO and Rh(D); D-variant deter-• 
mination, Kell. 
 Detection of irregular antibodies .• 
 Cross matching of blood samples for transfusion. • 
Indirect antiglobin test, direct antiglobin test. 
 Rhesus- and ABO-antagonism. • 
 Haematological biochemistry of erythrocytes4. 
 Detection and measurement of variant and minor (Hb • 
A2 and HbF) haemoglobins. 
 Red blood cell enzymes .• 
 Theoretical and clinical background5. 
 Haemoglobinopathies and thalassemias. • 
 Vitamin B12 and folic acid defi ciencies; iron status. • 
 Kinetics of blood cells and platelets. • 
 Enzymology of blood cells and platelets. • 
 Haemato-oncological abnormalities (leukaemias, lym-• 
phomas, polycythaemias). 
 Possible causes and background of anaemias. • 
 TTP, HELLP, DIC. • 
 Immunological determination of coagulation factors • 
and knowledge of coagulation abnormalities (factor 
defi ciency, increased fi brinolytic activity) and regula-
tion and monitoring of thrombosis and disseminated 
intravascular coagulation. The use of anticoagulant 
drugs. 
 Blood group antigens and other antigen systems as con-• 
sidered in blood transfusion (including genetics). 
 Selection criteria of donors for blood transfusion. • 
 Several types of transfusion reactions, foetal maternal • 
bleeding .
 Medical applications, clinical relevance and indi-• 
cations for the administration of blood and blood 
components. 
 Haematopoiesis and haemostasis physiology .• 
 Morphology and haematopoiesis6. 
 Morphological investigation of bone marrow smears in-• 
cluding different staining procedures. PAS staining for 
intracellular glycogen, Sudan black staining for lipids, 
iron staining, acid phosphatase, esterase and peroxidase 
staining. 
 Investigation of cellular characteristics and abnormali-• 
ties by fl ow cytometry. 
 Haemoglobinopathies. Haemoglobin electrophoresis on • 
cellulose acetate, in agar gel. Foetal heamoglobin test-
ing (Kleihauer, fl ow cytometric HbF determination). 
Molecular diagnostic approaches. 
 Investigation of anaemias, both congenital and acquired. • 
Ham test and sucrose test. 
 Detection of abnormal haemoglobin derivatives: spec-• 
trophotometric analysis. 
 Haemato-oncology, including cytogenetic and mo-• 
lecular diagnostic alterations of haematological 
malignancies. 
 Myelodysplasia. • 
 Ganglion exploration. • 
 Lymphoid system pathology. • 
 Haemostasis7. 
 Investigation of platelet function. PFA, throm-• 
boelastography. Infl uence on platelet aggregation by 
ADP-adrenaline, collagen, ristocetin, ADP, ATP, aracha-
donic acid. Determination of serotonin. Spontaneous 
aggregation. Clot retraction. Platelet factor III determi-
nation, glass pearl test. 
 Use of chromogenic substrates for the determination of • 
coagulation factors. 
 Detection of circulating inhibitors, thrombo test diluted • 
curve, cephalin dilution curve. 
 Protein S, protein C. • 
 VWD: VWag, VWrico, ADAMTS13. • 
 Theoretical background and clinical background and • 
knowledge of the following subjects: prekallikrein, high 
molecular kininogen determination, plasminogen, anti-
plasmin, plasminogen activators. 
 Thrombophilia testing (FV Leiden, FII, PAI, MTHFR), • 
(LAC testing: anti cardiolip etc). 
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 Thrombin activation: TAT, protrombin fragments F1 + 2, • 
D-dimer. 
 Knowledge of anticoagulant treatment as well in clini-• 
cal as in outpatient conditions. 
 Acute vascular diseases TTP, HUS, DIS. Place of plas-• 
mapheresis in treatment. 
 Immuno-haematology and blood banking8. 
 Typing of irregular (auto) antibodies; determination of • 
antibody titre. 
 Extended blood group typing (beyond ABO, Rhesus D • 
and Kell). 
 Investigation of transfusion reactions. • 
 Preparation and application of blood components. • 
 Organisation of blood banking. • 
 Typing of B and T lymphocytes. • 
 Platelet antibodies. • 
 Typing of leucocytes and tissue antigens. • 
 Recognition of cell markers using monoclonal • 
antibodies. 
 The application of plasmapheresis both in donors and • 
in patients. 
 Microbiology/virology (bacteriology, parasitology, and 
mycology) 
 General aspects1. 
 The investigation of biological samples in infectious 
diseases is different from the other specialities in that it 
requires general knowledge of pathogenic agents (bacteria 
or viruses) and of host reaction.
 Defi nition of infection and infectious disease: natural • 
bacteriological ecosystem. 
 Pathogenicity of bacteria and viruses; disinfection .• 
 General epidemiology of infection and infectious diseases. • 
 Diagnostic procedures 2. 
 Specimen selection and collection (blood, urine, spu-• 
tum, faeces, others). 
 Specimen processing: smears, staining, cultures in-• 
cluding cell cultures, susceptibility testing, antigen 
detection .
 Usual techniques for microbe and virus identifi cation • 
(including principal differential characteristics) .
 Molecular biology techniques for characterisation of • 
microbes and viral agents. 
 Bacteriological and viral serology. • 
 Bacteria and viruses3. 
 Succinct description of responsible bacteria and viruses in 
bacteriological and viral syndromes or diseases (including 
principal differential characteristics):
 Bacteria:  • Neisseria gonorrhoeae and  N. meningitidis, 
Staphylococcus aureus, Streptococcus pyogenes , (es-
pecially  S. agalactiae and  S. pneumoniae ,  Escherichia 
coli ,  Salmonella ,  Shigella and other enterobacteri-
aceae,  Vibrio cholerae ,  Pseudomonas aeruginosa , 
 Haemophilus infl uenzae ,  Clostridium perfringens ,  C. 
tetani, Bacteroides spp,  Listeria monocytogenes , 
 Legionella ,  Mycobacterium tuberculosis and others, 
 Treponema pallidum, Chlamydiae, Mycoplasma etc.
 Viruses:  Herpes (herpes simplex, herpes varicellae, • 
cytomegalovirus, Epstein-Barr virus), hepatitis A, B, 
C, D, E, human immunodefi ciency virus, enteroviruses 
(poliovirus), rubella, mumps, measles, parvovirus B19, 
RSV, myxovirus, rhinovirus, coronavirus, adenovirus, 
rotavirus, papillomavirus, rabies etc. 
 Bacteriological and viral syndromes or diseases4. 
 Epidemiology, main clinical signs, basis for biological 
diagnosis, treatment:
 Meninged syndrome .• 
 Septicaemic syndrome .• 
 Urinary and genital infections. • 
 Bacteriological and viral diarrhoeas. • 
 Respiratory infections. • 
 Human acquired immunodefi ciency syndrome. • 
 Sexually transmitted diseases. • 
 Hepatic virus infections. • 
 Cytomegalovirus infections. • 
 Antibiotics and antiviral agents 5. 
 Basic knowledge of antibiotics and antimicrobiological • 
therapy. 
 Antibiotic and antiviral sensitivity test. • 
 Antibiotic and antiviral resistant mechanisms. • 
 Medical parasitology (including mycology)6. 
 Epidemiology, main clinical signs, basis for biologi-6.1. 
cal diagnosis (including a succinct description of 
parasites and fungi without biochemical characteris-
tics), treatment.
 Amoebiasis:  • Entamoeba histolytica. 
 Giardiasis, cryptosporidiosis and uro-genital • 
trichomoniases. 
 Malaria. • 
 Toxoplasmosis. • 
 Intestinal, hepatic and urinary helminthiasis: • 
strongyloidiasis, ancylostomiasis, enterobiasis, as-
cariasis, schistosomiasis ( Schistosoma mansoni et 
 S. haematobium ) fascioliasis ( Fasciola hepatica ) 
taeniasis ( Taenia saginata ). 
 Fungal infections ( • Candida albicans ,  Cryptococcus 
neoformans etc). 
 Aspergillus infections ( • Aspergillus fumigatus ). 
 Dermatophyte infections ( • Microsporum canis , 
 Epidermophyton fl occosum ,  Trichophyton rubrum , 
 Trichophyton mentagrophytes ). 
 Leishmaniosis. • 
 Echinococcosis. • 
 Pneumocystosis. • 
 Filariosis. • 
 Usual techniques for parasite and fungus 6.2. 
identifi cation. 
 Immunological and molecular diagnosis of parasitic 6.3. 
and mycologic diseases. 
 Genetics, in vitro fertilisation 
 Biological genetics includes cytogenetics and molecular 
genetics 
Unauthenticated
Download Date | 8/2/19 12:18 PM
1326  Wieringa et al.: EC4 European Syllabus for Post-Graduate Training in CCLM
 Cytogenetics1. 
 At the end of his/her training, the clinical chemist must be 
able to appreciate the relevance of the prescription, evalu-
ate the cohesiveness of the results, to perform and supervise 
the realisation of a karyotype and an in situ hybridisation. 
 Karyotype1.1. 
 To know the different analysable materials and the • 
culture requirements. 
 To know the culture conditions according to the sample • 
and the indications (medium, support, culture time) .
 To perform chromosomal preparations as directed. • 
 To master the acquisition of the principal types of • 
chromosomal bands. 
 To perform high resolution karyotypes (replication • 
bands) .
 To perform microscopic examination, display cap-• 
ture on analyser and karyotype classifi cation. 
 To know how to supervise and critically analyse: • 
the quality of the chromosomal preparations and the 
resolution level of the chromosomal bands. 
 To appreciate the validity criteria of chromosomal • 
analysis. 
 Molecular cytogenetics 2. 
 To know how to perform in situ hybridisation fl uo-• 
rescent technique: centromeric probe, chromosome 
painting probe, specifi c probe of a locus on metaphase 
or interphase. 
 To acquire the necessary knowledge to perform compar-• 
ative genomic hybridisation on microarrays .
 To appreciate the validity criteria of molecular cytogene-• 
tics assays. 
 To be able to describe the analysis strategy of the under-
listed abnormalities and to recognise their diagnostic, prog-
nosis and/or therapeutic interest:
 Chromosome number abnormalities .• 
 Mosaicism. • 
 Structure abnormalities in equilibrium and disequilibrium. • 
 Chromosomal microrearrangement .• 
 Identifi cation of a chromosomal marker. • 
 Identifi cation of chromosomal variants. • 
 Chromosome fragility and chromosome breakage • 
syndromes .
 Molecular genetics3. 
 At the end of his training, the clinical chemist must be 
able to appreciate the prescription relevance, evaluate the 
cohesiveness of the results, perform and supervise the car-
rying out of molecular genetics analysis. 
 Molecular genetics procedures3.1. 
 To perform the different procedures of nucleic acid • 
extraction (genomic DNA, RNA, RNApolyA + ) .
 To perform the different identifi cation methods of • 
point mutations. 
 To perform the different identifi cation methods of • 
genomic mutations. 
 To perform the different methods of study of DNA • 
polymorphisms (SNP, microsatellites). 
 To perform the different nucleic acid quantifi cation • 
methods. 
 To perform the different methods of gene expres-• 
sion study at RNA level. 
 To acquire the necessary notions to perform and in-• 
terpret the DNA or cDNA microarrays techniques .
 To appreciate the validity criteria of molecular ge-• 
netics analysis. 
 To be able to describe the analysis strategy of the fol-3.2. 
lowing pathological types and to recognise their diag-
nostic, prognosis and/or therapeutic interest:
 Monogenic disorders (autosomal dominant, autosom-• 
al recessive, X-linked recessive, X-linked dominant). 
 Oligo- and polygenic disorders. • 
 Mitochondrial disorders. • 
 Reproductive medicine 4. 
 Basic knowledge4.1. 
 Sperm count. • 
 Sperm vitality and motility. • 
 Sperm morphology: normal spermatozoa and cells • 
other than spermatozoa. 
 Antibody coating of spermatozoa. • 
 Sperm preparation test .• 
 Interaction tests between spermatozoa and cervical • 
mucus. 
 Extended knowledge4.2. 
 Biochemical assay for accessory sex organ function. • 
 Computer-aided sperm analysis .• 
 Assessment of sperm DNA fragmentation and • 
decondensation .
 Knowledge of the WHO criteria for sperm analysis. • 
 In vitro fertilisation5. 
 Sperm preparation for fertilisation with frozen sperm or • 
from testicular or epidymal biopsy. 
 Fertilisation by conventional IVF. • 
 Fertilisation by ICSI technic and/or high magnifi cation • 
(IMSI). 
 In vitro maturation of the oocytes. • 
 Oocyte quality. • 
 Embryo culture from day 1 (pronuclei) to day 6 • 
(blastocysts). 
 Embryo quality. • 
 Blastocyst quality. • 
 Embryo biopsy .• 
 Embryo preparation for transfer .• 
 Cryopreservation of gametes (sperm and oocyte) and em-6. 
bryos (day 1 to 6).
 Slow cooling. • 
 Vitrifi cation. • 
 Examples of scientifi c and medical literature 
 1. Example textbooks 
 Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook 
of clinical chemistry and molecular diagnostics, 5th ed. St. 
Louis, MO: Elsevier Saunders, 2011. 
 Greiling H, Gressner AM, editors. Lehrbuch der Klinischen 
Chemie und Pathobiochemie, 3rd ed. Stuttgart: FK 
Schattauer Verlag, 1995. 
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 Thomas L, editor. Clinical laboratory diagnostics. Frankfurt 
am Main: T-H Books, 1998. 
 Johnstone A, Thorpe R, editors. Immunochemistry in prac-
tice. Oxford: Blackwell Scientifi c Inc, 1996. 
 Rose BD, Post T, Narins R. Clinical physiology of acid-
base and electrolyte disorders, 5th ed. New York: McGraw-
Hill Education Book Company, 2001. 
 Greenspan FS, Strewler GJ, editors. Basic & clinical endo-
crinology. Los Altos, CA: Appleton & Lange Medical 
Publications, 1997. 
 Felig P, Baxter JD, Frohman LA, editors. Endocrinology 
and metabolism. New York: McGraw-Hill Book Company, 
1995. 
 Sackett DL, Haynes RB, Tugwell P, editors. Clinical epi-
demiology, a basic science for clinical medicine. Boston: 
Little, Brown and Company, 1991. 
 Stites DP, Terr AI, Parslow TG, editors. Medical immunol-
ogy. London: Appleton & Lange, 2001. 
 Friedman RB, Young DS, editors. Effects of disease on 
clinical laboratory tests. Washington, DC: AACC Press, 
2001. 
 Young DS, editor. Effects of drugs on clinical laboratory 
tests. Washington, DC: AACC Press, 2001. 
 Young DS, editor. Effects of pre-analytical variables on clin-
ical laboratory tests. Washington, DC: AACC Press, 2007. 
 Richard-Lee GL, Foerster J, Lukens J, Wintrobe MM, edi-
tors. Wintrobe ’ s clinical haematology. Philadelphia, PA: 
Lea and Febiger, 1998. 
 Dacie JV, Lewis SM. Practical haematology, 11th ed. 
London: Churchill Livingstone, 2011. 
 Spivak JL, Eichner ER. The fundamentals of clinical hema-
tology. Cambridge: Harper and Row Publishers, 1993. 
 Bloom AL, Forbes CD, Thomas DD. Haemostasis and 
thrombosis. London: Churchill Livingstone, 1994. 
 Engelfriet CP, Contreras M, Mollison PL. Blood trans-
fusion in clinical medicine. Oxford: Blackwell Science Inc, 
1997. 
 Babior BM, Stossel TP. Haematology:  “ a pathophysiologi-
cal approach ” . New York: Churchill Livingstone, 1994. 
 Hall R, Malia RG, editors. Medical laboratory haematol-
ogy, 2nd ed. London: Butterworths, 1994. 
 Colman RW, Hirsh J, Marder VJ, Salzman EW, edi-
tors. Hemostasis and thrombosis; basic principles and 
clinical practice, 5th ed. Philadelphia, PA: JB Lippincott 
Company, 2006. 
 Stiene-Martin EA, Lotspeich-Steininger ChA, Koepke JA, 
editors. Clinical hematology: principles, procedures, cor-
relations. Philadelphia: JB Lippincott Company, 1998. 
 Harmening DM, editor. Clinical hematology and funda-
mentals of hemostasis, 5th ed. Philadelphia, PA: FA Davies 
Company, 2008. 
 Hoffbrand AV, Petit JE. Essential haematology, 5th ed. 
Oxford: Wiley-Blackwell Scientifi c Publications, 2006. 
 Adelberg EA, Jawetz E, Melnick JL. Medical microbiol-
ogy, 25th ed. New York: McGraw-Hill Medical, 2010. 
 Murray PR, Baron EJ, Pfaller MA, editors. Manual of 
clinical microbiology, 8th ed. Washington, DC: American 
Society for Microbiology, 2003. 
 Bangert SK, Marshall WJ, editors. Clinical biochemistry: 
metabolic and clinical aspects, 6th ed. London: Churchill 
Livingstone, 2008. 
 Lotze MT, Thomson AW. Measuring immunity. Basic sci-
ence and clinical practice. Amsterdam, Boston: Elsevier 
Academic Press, 2005. 
 Doucette LJ. Mathematics for the clinical laboratory, 2nd 
ed. Philadelphia, PA: Saunders Co., 2011. 
 2. Scientifi c and medical journals 
 Annals of Clinical Biochemistry • 
 Antimicrobial Agents and Chemotherapy • 
 Biochemia Medica ( http://www.biochemia-medica.• 
com/ ) 
 British Medical Journal • 
 Clinical Chemistry • 
 Clinical Chemistry and Laboratory Medicine • 
 Clinica Chimica Acta • 
 Current Advances in Clinical Chemistry • 
 European Journal of Clinical Microbiology and • 
Infectious Diseases 
 Journal of Biological Chemistry • 
 Journal of Clinical Endocrinology and Metabolism • 
 Journal of Clinical Microbiology • 
 Nature • 
 New England Journal of Medicine • 
 Scandinavian Journal of Clinical & Laboratory • 
Investigation 
 Science • 
 The Lancet • 
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